Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
    August 01, 2015 - � Radiation therapy: High-energy radiation beams are used to kill cancer cells in and around the tumor … Radiation therapy uses high-energy radiation beams to kill cancer cells in and around a tumor. … � It can shrink tumors, reduce some symptoms, and relieve pain. … that hits healthy tissues around the tumor. … The goal is to: � Target the tumor with the right amount (dose) of radiation � Limit the radiation
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
    July 20, 2021 - MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting cancers … Among all cancers, it is third in incidence and cause of cancer death for both men and women.1 In addition … entails exposure to low-dose ionizing radiation (range, 0.8 to 5.3 mSv), which may increase the risk of malignancy … Interval cancers in a population-based screening program for colorectal cancer in Catalonia, Spain. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.
  3. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49870/psn-pdf
    August 10, 2019 - patients who used low-dose aspirin had markedly higher sensitivity for detecting advanced colorectal neoplasmscancer screening.(13) A population cohort study found that 6% of colorectal cancers develop within … of the patient, family history of gastrointestinal neoplasia, and missed or incompletely excised lesions … or development of interval cancers. … Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life
  4. effectivehealthcare.ahrq.gov/health-topics/cancer-children
  5. www.uspreventiveservicestaskforce.org/Home/GetFileByID/1932
    April 01, 2015 - Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening Technical Report … Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening Prepared … Women with large breasts had higher risk of radiation-induced cancer (mean LAR, 265 cancers and 35 deaths … per 100,000 women; 95th percentile, 481 cancers and 63 deaths per 100,000 women) compared to other … women (mean LAR, 112 cancers and 15 deaths per 100,000 women; 95th percentile, 187 cancers and 24 deaths
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/BMh7ctXLmgRXhC4CVZGJNH
    April 01, 2015 - Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening Technical Report … Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening Prepared … Women with large breasts had higher risk of radiation-induced cancer (mean LAR, 265 cancers and 35 deaths … per 100,000 women; 95th percentile, 481 cancers and 63 deaths per 100,000 women) compared to other … women (mean LAR, 112 cancers and 15 deaths per 100,000 women; 95th percentile, 187 cancers and 24 deaths
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
    November 01, 2021 - (n = 10 286), which had about 4 years of follow-up, 0.35% of examinations revealed an extracolonic malignancy … Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics … Association between early stage colon neoplasms and false-negative results from the fecal immunochemical … Accuracy of CT colonography for detection of large adenomas and cancers. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.
  8. www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
    April 15, 2012 - via ultrasonography, serum tumor markers, or pelvic examination was not recommended (D recommendation … , serum tumor markers, or pelvic examination was not recommended (D recommendation) 3 . … cancer and ovarian tumors with uncertain behavior. … of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancermalignancy.
  9. psnet.ahrq.gov/issue/overdiagnosis-low-dose-computed-tomography-screening-lung-cancer
    August 04, 2021 - Overdiagnosis in low-dose computed tomography screening for lung cancer. … lung cancer that would not otherwise become clinically apparent—or cancer overdiagnosis . … Using these calculations, approximately 20% of cancers detected by LDCT screening represented overdiagnosis … Overdiagnosis in low-dose computed tomography screening for lung cancer. … August 3, 2016 Errors in the MRI evaluation of musculoskeletal tumors and tumorlike lesions
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
    January 01, 2019 - meta-analysis supports existence of effect modification for immunotherapy by PD-L1 status in gastric cancer … Multiple other effect modifiers evaluated. 41436 MAGIC Primary tumor location Yes Overall survival Hazard … Multiple other effect modifiers evaluated. 47286 KEYNOTE-585 Primary tumor location Yes Overall survival … evaluating the correlation between TUBB3 expression and taxane-based chemotherapy for gastric and other cancers … Cut point for dichotomization of unclear clinical relevance. 43481 JACCRO GC-07 Tumor location within
  11. hcup-us.ahrq.gov/datainnovations/ICD-10_DXCCS_Trends112817.pdf
    November 28, 2017 - 0.8 –2.9 43: Malignant neoplasm without specification of site 1,064 1,072 1,308 0.8 22.0 44: … 18,167 22,433 8.4 23.5 43: Malignant neoplasm without specification of site 4,728 4,931 3,062 4.3 … 45: Maintenance chemotherapy; radiotherapy 500 606 834 21.2 37.6 46: Benign neoplasm of uterus … 15,610 17,381 17,512 11.3 0.8 47: Other and unspecified benign neoplasm 20,852 23,784 22,214 14.1 … of pancreas 2,592 2,994 3,019 15.5 0.8 46: Benign neoplasm of uterus 15,610 17,381 17,512 11.3 0.8
  12. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-radiation-induced-breast-cancer-and-breast-/breast-cancer-screening-january-2016
    January 11, 2016 - detection rates, and cancer stage at detection, we estimated thresholds at which tumors become screen-detectable … The effect of screening on breast cancer natural history was assessed by modeling continuous tumor growth … , in which tumors detected before they reached their fatal diameter were cured and those detected past … Tumour development, histology and grade of breast cancers: prognosis and progression. … The MISCAN-Fadia continuous tumor growth model for breast cancer.
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/breast-cancer-screening
    April 30, 2024 - review as stage IIB or higher, which encompasses tumors with local lymph node involvement or distant … synthetic digital mammography. 33 , 47 Supplemental Screening The Dense Tissue and Early Breast Neoplasm … Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. … Proportion of Screen-Detected Invasive Cancers Diagnosed (Advanced Stage [II or Higher], Tumor Size > … of control group interval tumors) was statistically significant; second-round results not yet published
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
    February 22, 2012 - and Endobronchial Obstruction Due to Advanced Lung Tumors I. … recurrence, noncancer-related mortality, and second malignancies.2, 3 Malignant Endobronchial Obstruction … Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non- small-cell' OR 'non-small cell' OR 'non … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non- small-cell' OR 'non-small cell' OR 'non
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35 Solid tumors: 19/35 (53%) Hematologic: 17/35 (47%) TP with new cancer:
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35 Solid tumors: 19/35 (53%) Hematologic: 17/35 (47%) TP with new cancer:
  17. hcup-us.ahrq.gov/reports/natstats/his95/appaa.htm
    September 01, 1998 - 20260 20261 20262 20263 20264 20265 20266 20267 20268 2340 2348 2349 7951 42 Secondary malignancies … 1975 1976 1977 1978 1980 1981 1982 1983 1984 1985 1986 1987 19881 19882 19889 43 Malignantneoplasm without specification of site 1990 1991 44 Neoplasms of unspecified nature or uncertain … 2399 45 Maintenance chemotherapy, radiotherapy V580 V581 V661 V662 V671 V672 46 Benignbenign neoplasm V1272 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
    December 16, 2014 - PIVOT conducted in the US and primarily involved men with PSA detected tumors. … Nearly 80% of SPCG-4 subjects had T2 (palpable) tumors vs. only about 45% in PIVOT. P 59. … The report focuses only on T1 through T3a cancers. … , Reduces the risk of a second malignant neoplasms (SMN) in prostate patients compared with contemporary … Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x- ray therapy for
  19. www.ahrq.gov/cahps/surveys-guidance/cancer/develop-cancer-surveys.html
    March 01, 2017 - Development of the CAHPS Cancer Care Survey The CAHPS ® Cancer Care Survey was developed and … It was sponsored by AHRQ’s CAHPS program and the Outcomes Research Branch of the National Cancer Institute … AIR and Mayo Clinic began by developing a conceptual framework for understanding patient-centered cancer … -item survey that included 41 questions designed to measure patient experiences in eight domains of cancer … They also conducted testing of the proposed measures with patients who had received cancer treatment.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
    January 01, 2016 - includes tumors confined to the prostate (T1–T2) and tumors with extracapsular extension but without … be influenced by factors such as patient age and health at the time of diagnosis, life expectancy, tumor … therapy (e.g., androgen deprivation therapy [ADT]) Interstitial brachytherapy: a strategy whereby tumor … –� Recommended treatment options based on the patient’s age, health status, life expectancy, and tumor … stage –� The potential for tumor eradication with treatment –� Available evidence for the efficacy and